Question 1

Is Atomoxetine;Methylphenidate;Lisdexamfetamine currently in shortage?

Accepted Answer

Yes. As of the latest regulator updates, Atomoxetine;Methylphenidate;Lisdexamfetamine has 5 active shortage notices across 3 countries (United States, European Union, Ireland). Status is refreshed daily from official regulatory sources.

Question 2

Why is Atomoxetine;Methylphenidate;Lisdexamfetamine in shortage?

Accepted Answer

Regulators attribute the current Atomoxetine;Methylphenidate;Lisdexamfetamine shortages to supply-chain disruption, regulatory action, causes not stated by the regulator. The exact cause varies by country and product — each notice on this page links to the official source.

Question 3

Where does this Atomoxetine;Methylphenidate;Lisdexamfetamine shortage data come from?

Accepted Answer

Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ regulators across 50+ countries and never publishes unsourced shortage claims.

Country	Severity	Notices	Since	Est. resolution	Source
United States	high	2	29 Jan 2025	—	FDA MedWatch
European Union	high	1	18 Dec 2023	—

Atomoxetine;Methylphenidate;Lisdexamfetamine shortage status

Where Atomoxetine;Methylphenidate;Lisdexamfetamine is in shortage

Why Atomoxetine;Methylphenidate;Lisdexamfetamine is in shortage

Recent shortage history

Frequently asked questions

Get alerted when Atomoxetine;Methylphenidate;Lisdexamfetamine status changes